Showing results (41-50 of 431) with videos related to
Sort By:
Pageof 44
Journal of Cancer Research and Clinical Oncology|May 13, 2015
Clinicopathological significance of cancer stem-like cell markers in high-grade neuroendocrine carcinoma of the lungMasahiro Morise, Tomoyuki Hishida, Akiko Takahashi, et al.The Tohoku Journal of Experimental Medicine|September 6, 2007
Problems with registration-directed clinical trials for lung cancer in JapanIkuo Sekine, Hiroshi Nokihara, Noboru Yamamoto, et al.JTO Clinical and Research Reports|September 30, 2021
The Long Half-Life of Programmed Cell Death Protein 1 Inhibitors May Increase the Frequency of Immune-Related Adverse Events After Subsequent EGFR Tyrosine Kinase Inhibitor TherapyYuki Shinno, Yasushi Goto, Mayu Ohuchi, et al.Cancer Science|February 19, 2019
Safety and effectiveness of alectinib in a real-world surveillance study in patients with ALK-positive non-small-cell lung cancer in JapanNoriyuki Masuda, Yuichiro Ohe, Akihiko Gemma, et al.Cancer Science|October 8, 2016
Bevacizumab for non-small-cell lung cancer: A nested case control study of risk factors for hemoptysisKoichi Goto, Masahiro Endo, Masahiko Kusumoto, et al.Cancer Treatment Reviews|May 18, 2004
Treatment of small cell lung cancer in the elderly based on a critical literature review of clinical trialsIkuo Sekine, Noboru Yamamoto, Hideo Kunitoh, et al.Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|August 15, 2024
Nonreversed great saphenous vein grafts for vascular reconstruction after resection of lower-limb sarcomaMasaki Arikawa, Satoshi Akazawa, Daisuke Kageyama, et al.Lung Cancer (Amsterdam, Netherlands)|June 20, 2006
Common arm analysis: one approach to develop the basis for global standardization in clinical trials of non-small cell lung cancerIkuo Sekine, Hiroshi Nokihara, Noboru Yamamoto, et al.BMC Cancer|April 8, 2018
The first case of SMARCB1 (INI1) - deficient squamous cell carcinoma of the pleura: a case reportKazushi Yoshida, Yutaka Fujiwara, Yasushi Goto, et al.International Cancer Conference Journal|October 14, 2024
Ileal perforation at the site of peritoneal metastasis with intestinal infiltration by dual EGFR-VEGF pathway inhibition in an EGFR-mutant non-small cell lung cancer patientTomomi Sanomachi, Tatsuya Yoshida, Ryoko Inaba Higashiyama, et al.Pageof 44